GS 5CC (Requip XL 8 mg)
Generic Name: ropinirole
Pill imprint GS 5CC has been identified as Requip XL 8 mg.
Requip XL is used in the treatment of parkinson's disease; periodic limb movement disorder and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Requip XL 8 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- ropinirole
- Imprint:
- GS 5CC
- Strength:
- 8 mg
- Color:
- Red
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00007-4888
- Inactive Ingredients:
- carboxymethylcellulose sodium
silicon dioxide
glyceryl dibehenate
hydrogenated castor oil
hypromelloses
lactose monohydrate
magnesium stearate
maltodextrin
mannitol
povidone
More about Requip XL (ropinirole)
Consumer resources
- Other brands: Requip
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
